(Q36347976)

English

Harm or benefit of hormonal treatment in metastatic low-grade endometrial stromal sarcoma: single center experience with 10 cases and review of the literature

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

Harm or benefit of hormonal treatment in metastatic low-grade endometrial stromal sarcoma: single center experience with 10 cases and review of the literature (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

endometrial stromal sarcoma

1 reference

based on heuristic

inferred from title

stromal sarcoma

1 reference

based on heuristic

inferred from title

author name string

Daniel Pink

1

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

Tanja Lindner

2

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

Alicia Mrozek

3

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

Albrecht Kretzschmar

4

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

Peter C Thuss-Patience

5

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

Bernd Dörken

6

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

Peter Reichardt

7

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

language of work or name

0 references

publication date

20 December 2005

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

Gynecologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

101

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

464-469

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

Endometrial stromal sarcoma of the uterus: analysis of 25 patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.010

7 January 2021

Mesenchymal tumors of the uterus. I. A clinical and pathological study of 53 endometrial stromal tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.010

7 January 2021

Endometrial Stromal Sarcoma: Analysis of Treatment Failures and Survival

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.010

7 January 2021

Endometrial stromal sarcoma of twenty cases

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.010

7 January 2021

Pulmonary metastases from a low-grade endometrial stromal sarcoma confirmed by chromosome aberration and fluorescence in-situ hybridization approaches: a case of recurrence 13 years after hysterectomy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.010

7 January 2021

Endometrial stromal sarcoma with a sole t(X;17) chromosome change: report of a case and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.010

7 January 2021

Endometrial stromal tumors: an update on a group of tumors with a protean phenotype.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.010

7 January 2021

The classification of a uterine sarcoma as 'high-grade endometrial stromal sarcoma' should be abandoned

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.010

7 January 2021

A case-control study of risk factors for sarcomas of the uterus. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.010

7 January 2021

Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.010

7 January 2021

Low-grade endometrial stromal sarcoma: hormonal aspects

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.010

7 January 2021

A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynecologic Oncology Group Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.010

7 January 2021

Treatment of uterine sarcomas.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.010

7 January 2021

Treatment of endometrial stromal tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.010

7 January 2021

Endometrial stromal sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.010

7 January 2021

Radiation therapy in the treatment of endometrial stromal sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.010

7 January 2021

Uterine sarcomas--the biggest challenge?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.010

7 January 2021

Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.010

7 January 2021

Detection of pulmonary metastasis of low-grade endometrial stromal sarcoma 25 years after hysterectomy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.010

7 January 2021

Low-grade endometrial stromal sarcoma with cardiovascular involvement--a report of three cases

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.010

7 January 2021

Long-term survival of patients given hormonal therapy for metastatic endometrial stromal sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.010

7 January 2021

Endometrial stromal sarcoma: a clinicopathologic study of 11 cases with determination of estrogen and progestin receptor levels in three tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.010

7 January 2021

Recurrence of prolactin-producing endometrial stromal sarcoma with sex-cord stromal component treated with progestin and aromatase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.010

7 January 2021

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.010

7 January 2021

Uterine sarcoma associated with tamoxifen use.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.010

7 January 2021

Uterine sarcoma in patients receiving tamoxifen therapy. Apropos of 2 cases

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.010

7 January 2021

Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.010

7 January 2021

Association of tamoxifen and uterine sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.010

7 January 2021

Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.010

7 January 2021

Increased risk of malignant mullerian tumor of the uterus among women with breast cancer treated by tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.010

7 January 2021

Hormone replacement therapy and endometrial cancer risk: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.010

7 January 2021

Risk of Endometrial Cancer Following Estrogen Replacement With and Without Progestins

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.010

7 January 2021

Low-potency oestrogen and risk of endometrial cancer: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.010

7 January 2021

Uterine stromal sarcoma following tamoxifen treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.010

7 January 2021

High-grade endometrial stromal sarcoma after treatment with tamoxifen in a patient treated for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.010

7 January 2021

Endolymphatic stromal myosis associated with tamoxifen use.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.010

7 January 2021

Low-grade endometrial stromal sarcoma preoperative treatment with Depo-Lupron and Megace

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.010

7 January 2021

Proliferative stromatosis of the uterus with pulmonary metastases. Remission following treatment with a longacting synthetic progestin: a case report

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.010

7 January 2021

Endometrial stromal sarcoma: objective response to letrozole

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.010

7 January 2021

Low-grade endometrial stromal sarcoma treated with the aromatase inhibitor letrozole.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.010

7 January 2021

Cisplatin-based chemotherapy regimen (DECAV) for uterine sarcomas.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.010

7 January 2021

Treatment of stage IV "high-grade" endometrial stromal sarcoma with ifosfamide, adriamycin, and cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.010

7 January 2021

Complete remission of widely metastatic endometrial stromal sarcoma following combination chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.11.010

7 January 2021

Identifiers

10.1016/J.YGYNO.2005.11.010

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

release_lnrksckmbray3aiuoq3e5m45hq

1 reference

https://api.fatcat.wiki/v0/release/lnrksckmbray3aiuoq3e5m45hq

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36347976&oldid=1843836806"